Icahn Capital 13F holdings, Q4 2008
Holdings as of December 31, 2008 · filings on SEC EDGAR · latest filing →
Icahn Capital disclosed 21 US equity positions worth $2.7bn in its Q4 2008 13F filing. The largest position was YAHOO INC at 26.9% of the reported book, followed by BIIB and MOTOROLA INC. Against the Q3 2008 filing, it opened 4 new positions, added to 7 and reduced 5 among the top 21 holdings.
What did Icahn Capital own in Q4 2008? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2008 |
|---|---|---|---|---|---|---|---|
| 1 | YAHOO INC | 26.9% | $737.5m | 60,452,099 | 10% | added | |
| 2 | BIIB BIOGEN IDEC INC | Healthcare | 22.3% | $612.5m | 12,860,205 | -8% | reduced |
| 3 | MOTOROLA INC | 19.4% | $530.7m | 119,790,447 | -17% | reduced | |
| 4 | ANADARKO PETE CORP | 10.7% | $293.7m | 7,617,876 | -53% | reduced | |
| 5 | WMB WILLIAMS COS INC | Energy | 9.2% | $253.0m | 17,475,520 | 142% | added |
| 6 | AMYLIN PHARMA | 4.5% | $124.0m | 11,426,157 | 7% | added | |
| 7 | LIONS GATE | 1.8% | $49.3m | 8,959,668 | 109% | added | |
| 8 | ENDO PHARMA | 1.4% | $39.0m | 1,506,080 | – | new | |
| 9 | CYBERONICS INC | 1.2% | $33.3m | 2,008,612 | 0% | held | |
| 10 | ENZON PHARMA | 0.5% | $14.2m | 2,457,683 | 0% | held | |
| 11 | BLOCKBUSTER INC | 0.5% | $13.3m | 10,523,840 | 0% | held | |
| 12 | EXEL EXELIXIS INC | Healthcare | 0.4% | $11.8m | 2,357,110 | 80% | added |
| 13 | GUARANTY FINL | 0.3% | $8.4m | 14,696,320 | 454% | added | |
| 14 | LIFE TECHNO | 0.2% | $4.6m | 196,507 | – | new | |
| 15 | TTWO TAKE-TWO INTER | Communication Services | 0.1% | $4.1m | 541,128 | 17% | added |
| 16 | FOR FORESTAR REAL | 0.1% | $3.8m | 397,720 | -85% | reduced | |
| 17 | WENDYS ARBYS | 0.1% | $3.2m | 643,590 | – | new | |
| 18 | BLOCKBUSTER INC | 0.1% | $2.9m | 4,452,905 | 0% | held | |
| 19 | MEDAREX INC | 0.1% | $1.7m | 313,040 | – | new | |
| 20 | AM6 AMICUS THERA | 0.0% | $1.2m | 145,427 | -28% | reduced | |
| 21 | ADVENTRX PHARMA | 0.0% | $277.0k | 3,459,459 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.